Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

QNCX

Quince Therapeutics, Inc.

CIK 0001662774 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$33.93
↑ 1.82 (5.67%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$34.51M
P/E Ratio
-0.37
EPS
-1.68
Dividend Yield
Not covered
52W Position
96%
Beta
1.94

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-0.98
P/S
Not covered
EV/Revenue
Not covered
ROE
261.8%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 96%
$0.08$35.41

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$83.98M
Total Assets
$93.52M
Free Cash Flow
-$41.78M

Recent news